|
rdfs:label
|
"Gamma-aminobutyric acid type A receptor gamma1 subunit"@nl
"Gamma-aminobutyric acid type A receptor subunit gamma1"@en
|
|
skos:altLabel
|
"GABA(A) receptor subunit gamma-1"@en
|
|
"GABA(A) receptor, gamma"@en
|
|
"GABRG1"@en
|
|
"gamma-1 polypeptide"@en
|
|
"gamma-aminobutyric acid (GABA) A receptor, gamma 1"@en
|
|
"gamma-aminobutyric acid receptor subunit gamma-1"@en
|
|
"gamma-aminobutyric acid type A receptor gamma1 subunit"@en
|
|
schema:description
|
"humanes Protein"@de
"mammalian protein found in Homo sapiens"@en
"menselijk eiwit"@nl
"protein"@sv
"protein"@id
"proteinë"@sq
"protèin"@ace
"protéine humaine"@fr
"білок людини"@uk
"بروتين بشري"@ar
|
|
schema:dateModified
|
"2023-12-03T11:58:38+00:00"^^xsd:dateTime
|
|
schema:version
|
2022953406
|
|
wikibase:identifiers
|
5
|
|
wikibase:sitelinks
|
0
|
|
wikibase:statements
|
76
|
|
p:P129
|
wd:statement/Q21113326-2BFA0030-7B86-43BC-AB97-6E750F0B7EDD
|
|
wd:statement/Q21113326-3A6BE66E-64F6-43A8-88D4-0233709A7113
|
|
wd:statement/Q21113326-78A02285-594E-4F68-9261-997A15CB1518
|
|
wd:statement/Q21113326-8874DC2B-D3A9-4EB7-B408-4CA077D4D1E6
|
|
wd:statement/Q21113326-91B87047-E420-49C3-9BF3-480031F97A57
|
|
wd:statement/Q21113326-936F33C7-B140-40D3-894C-FF7A22D0690C
|
|
wd:statement/Q21113326-A2754E0C-85D1-44B9-8A66-4E1796426BEA
|
|
wd:statement/Q21113326-A3FB6332-E910-4AFD-8C53-26E1DE135062
|
|
wd:statement/Q21113326-A586A8C8-7785-40A7-B5AE-2D44DEB50D86
|
|
wd:statement/Q21113326-A625ECAE-FCF7-4E3F-ABB6-25DA302D99B4
|
|
wd:statement/Q21113326-A98E646C-C900-4F06-BF8E-FACBDB43B3F4
|
|
wd:statement/Q21113326-AC0B42CD-7631-4967-A65F-44C9F6AD6C6B
|
|
wd:statement/Q21113326-CE234D08-EFC2-42D5-B5BB-249D67BE0296
|
|
wd:statement/Q21113326-D29639C0-E83B-4B68-856E-74544D6FA83C
|
|
p:P2888
|
wd:statement/Q21113326-26CAE158-EAB9-4C1E-8449-78DE3B79093B
|
|
wd:statement/Q21113326-E97690EC-8FEE-4B78-8FB4-02DC0FD8971E
|
|
wd:statement/Q21113326-F3EA7A55-ABFB-48B9-8E63-461AD3A87EAB
|
|
p:P31
|
wd:statement/Q21113326-458867D1-8949-41D1-B674-0866F566C340
|
|
p:P352
|
wd:statement/Q21113326-1A0ED22A-268F-44FA-BF55-9AFC885FC16F
|
|
p:P361
|
wd:statement/Q21113326-0DD40246-6C31-41B7-9E95-4A1BE0C416D5
|
|
wd:statement/Q21113326-14124CD7-9CE6-42D7-BBB3-78D91E07F3C9
|
|
wd:statement/Q21113326-2A104EA8-91B1-4E3B-90F7-146B60C325AE
|
|
wd:statement/Q21113326-43C18D15-8573-4779-B391-AD5B23DC2FCC
|
|
wd:statement/Q21113326-4F62B0F7-9E5B-4625-B4F5-738A01015B4F
|
|
wd:statement/Q21113326-7DAF9408-D40F-405F-8BB9-7BD036B6442F
|
|
p:P527
|
wd:statement/Q21113326-6C408FE4-642A-4427-8E43-E405F7B4564E
|
|
wd:statement/Q21113326-BB0A9BFC-A3CB-4A18-878C-5966DD2FF221
|
|
wd:statement/Q21113326-E167ADA3-D9CE-42F6-8941-874565019C77
|
|
p:P637
|
wd:statement/Q21113326-0C4F83F4-A088-46E6-A541-8C8D8505632E
|
|
wd:statement/Q21113326-1C437631-60FF-4359-92C3-2E12AEAF4491
|
|
p:P680
|
wd:statement/Q21113326-124F1902-03C1-4D9E-8943-8C57AB6ED20B
|
|
wd:statement/Q21113326-2BEE0DB9-1118-497F-94A8-5086B65A140D
|
|
wd:statement/Q21113326-2CD680F1-5FEA-414E-B50C-6F91E9A3EB54
|
|
wd:statement/Q21113326-423CDF26-AF78-4648-8ACF-117BE6E0D815
|
|
wd:statement/Q21113326-4C5C58F4-C13E-4F64-B996-9EFA3CCF2838
|
|
wd:statement/Q21113326-6AE9AA43-32D4-4DEF-824A-35D7B18D94F5
|
|
wd:statement/Q21113326-7A7E6CBC-365F-44FC-9E96-FDC5B9FD5A63
|
|
wd:statement/Q21113326-BB0D9A99-7A68-497D-974B-917365A81857
|
|
wd:statement/Q21113326-C18A185E-107F-43F5-B907-78EBDFEF04F2
|
|
wd:statement/Q21113326-C791FAA0-CD96-4F98-92D1-77ABDD175847
|
|
wd:statement/Q21113326-CD6F02A4-169B-487F-8270-19ECF2E3C8A3
|
|
wd:statement/Q21113326-E0D454D7-AE10-4713-9310-46291D03F9DE
|
|
wd:statement/Q21113326-EE487CAE-8141-400A-828A-6D3F90E8A3D0
|
|
p:P681
|
wd:statement/Q21113326-0B06EA67-CEB2-490C-95A9-C3EC4BF5C06C
|
|
wd:statement/Q21113326-36083265-FEBC-4591-A2E4-305645900BAD
|
|
wd:statement/Q21113326-5B41DAAF-6475-4B47-BA36-DF3727848424
|
|
wd:statement/Q21113326-5C11CD0A-98A9-41EC-9C53-801B811211EC
|
|
wd:statement/Q21113326-636C609E-03F3-474F-B384-64B21753BB76
|
|
wd:statement/Q21113326-7F2B1F1B-E6D5-4B33-9812-56412FF9910C
|
|
wd:statement/Q21113326-86F1BD00-C91E-4B82-9CF8-D6E6FCCC19E8
|
|
wd:statement/Q21113326-93AE298B-C1F8-44B5-BBCE-708D56695B48
|
|
wd:statement/Q21113326-CDCB9CCF-F901-4956-963D-3C12E948F83A
|
|
wd:statement/Q21113326-D3D5D299-4C58-4F87-AB2B-F413464F3764
|
|
wd:statement/Q21113326-DA4C2072-F1F9-4778-9370-DA23BB26239D
|
|
wd:statement/Q21113326-DFBC32E3-7372-4598-9920-A0001856315D
|
|
wd:statement/Q21113326-F2C94E34-CB4E-463B-B7A7-3C38A8E1E81F
|
|
wd:statement/Q21113326-F48A17EE-9B31-4BFE-BD8A-2133455DF592
|
|
p:P682
|
wd:statement/Q21113326-09B3F2FC-C113-4F6A-B037-49C4B8AA2EE1
|
|
wd:statement/Q21113326-271D6D94-457E-4BFC-95A1-E4B881A6FC65
|
|
wd:statement/Q21113326-36640C11-B2C6-48E8-8328-FE12C1507127
|
|
wd:statement/Q21113326-3CA295E7-C8F0-4CAE-AFB1-3562D1E8B77A
|
|
wd:statement/Q21113326-3CA48466-8A54-461A-8B6A-BC60B92C9F6D
|
|
wd:statement/Q21113326-56E407DC-687F-43BA-960D-0A742C7A9916
|
|
wd:statement/Q21113326-6D0BABD6-E0F0-4D1A-8628-A4367BB9F3D2
|
|
wd:statement/Q21113326-7B277CA9-8115-4800-9722-1450C51BAF09
|
|
wd:statement/Q21113326-8AD80992-0705-4FB4-95CB-755DA99D672F
|
|
wd:statement/Q21113326-932C5B68-2FA8-48C1-9C4E-9F86F30EC4F2
|
|
wd:statement/Q21113326-B2B5222F-7727-4840-9275-4AC0000FA8AD
|
|
wd:statement/Q21113326-BB61E255-D9EF-46CE-932F-AA2D6532D513
|
|
wd:statement/Q21113326-C9786DA8-522D-4356-9092-598E01A985A2
|
|
wd:statement/Q21113326-CDEEC22C-E16D-4E9E-889F-6C47FB2E3431
|
|
wd:statement/Q21113326-E88BECD7-3491-4CC6-AA48-330E9FE01217
|
|
p:P702
|
wd:statement/Q21113326-3AD77278-E7C0-462B-BDCF-C487E31A391F
|
|
p:P703
|
wd:statement/Q21113326-F12B384E-EAC3-410C-B1F3-CBC5CC178F56
|
|
p:P705
|
wd:statement/Q21113326-77FA8B15-1117-4C3B-927C-4A4CF5B23934
|
|
p:P7260
|
wd:statement/Q21113326-fc1d81bf-480b-70f9-b412-f51fef134b9d
|
|
p:direct-normalized/P352
|
<http://purl.uniprot.org/uniprot/Q8N1C3>
|
|
p:direct-normalized/P637
|
<http://purl.uniprot.org/refseq/NP_775807>
|
|
<http://purl.uniprot.org/refseq/XP_016863479>
|
|
wdt:P129
|
metharbital
|
|
triclofos
|
|
butalbital
|
|
chlordiazepoxide
|
|
diazepam
|
|
prazepam
|
|
topiramate
|
|
clotiazepam
|
|
allopregnanolone
|
|
chlordiazepoxide hydrochloride
|
|
clorazepate dipotassium
|
|
methohexital sodium
|
|
pentobarbital sodium
|
|
picrotoxin
|
|
wdt:P2888
|
<http://purl.uniprot.org/uniprot/Q8N1C3>
|
|
<https://identifiers.org/uniprot:Q8N1C3>
|
|
<https://www.ncbi.nlm.nih.gov/protein/Q8N1C3>
|
|
wdt:P31
|
protein
|
|
wdt:P352
|
"Q8N1C3"
|
|
wdt:P361
|
Gamma-aminobutyric-acid A receptor, gamma 1 subunit
|
|
Neurotransmitter-gated ion-channel transmembrane domain superfamily
|
|
Neurotransmitter-gated ion-channel ligand-binding domain superfamily
|
|
Neurotransmitter-gated ion-channel ligand-binding domain, protein family
|
|
Neurotransmitter-gated ion-channel transmembrane domain, protein family
|
|
Neurotransmitter-gated ion-channel, conserved site, protein family
|
|
wdt:P527
|
Neurotransmitter-gated ion-channel, conserved site
|
|
Neurotransmitter-gated ion-channel ligand-binding domain
|
|
Neurotransmitter-gated ion-channel transmembrane domain
|
|
wdt:P637
|
"NP_775807"
|
|
"XP_016863479"
|
|
wdt:P680
|
transmembrane signaling receptor activity
|
|
chloride channel activity
|
|
ion channel activity
|
|
benzodiazepine receptor activity
|
|
extracellular ligand-gated ion channel activity
|
|
GABA receptor binding
|
|
GABA-A receptor activity
|
|
inhibitory extracellular ligand-gated ion channel activity
|
|
GABA-gated chloride ion channel activity
|
|
transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential
|
|
wdt:P681
|
integral component of membrane
|
|
membrane
|
|
neuron projection
|
|
integral component of plasma membrane
|
|
postsynaptic membrane
|
|
chloride channel complex
|
|
receptor complex
|
|
dendrite membrane
|
|
synapse
|
|
cell junction
|
|
GABA-A receptor complex
|
|
postsynapse
|
|
plasma membrane
|
|
wdt:P682
|
chemical synaptic transmission
|
|
ion transport
|
|
chloride transport
|
|
ion transmembrane transport
|
|
regulation of membrane potential
|
|
nervous system process
|
|
chloride transmembrane transport
|
|
gamma-aminobutyric acid signaling pathway
|
|
synaptic transmission, GABAergic
|
|
signal transduction
|
|
regulation of postsynaptic membrane potential
|
|
wdt:P702
|
GABRG1
|
|
wdt:P703
|
man
|
|
wdt:P705
|
"ENSP00000295452"
|
|
wdt:P7260
|
"1.A.9.5.4"
|